Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Immunology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent webcasts/CME - Immunology
    Role of Biologic Therapy for the Autoinflammatory Syndromes
    Autoimmune and Inflammatory Disorders from Bench to Bedside
    Advances in Hereditary Angioedema Treatment: Considerations, Criteria & the New Therapy Options for Treatment & Prevention of HAE Attacks
    Sublingual Immunotherapy (SLIT) for Allergic Rhinitis The Latest Evidence

    Webcasts/CME archive

     Recent news - Immunology
      European Medicines Agency Reaffirms Efficacy, Safety of H1N1 Vaccines - (DGNews)
      Health Canada Approves Unadjuvanted H1N1 Vaccine - (DGNews)
      H1N1 Monovalent Vaccine Approved in Switzerland - (DGNews)
      Pregnant Women Show Strong Immune Response to One Dose of H1N1 Vaccine - (DGNews)
      Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA - (DGDispatch)

      News archive

       Recent cases - Immunology
        Ocular Disorders as the Prevailing Manifestations of Antiphospholipid Syndrome: A Case Series
        Primary Tubercular Liver Abscess in an Immunocompetent Adult: A Case Report
        High Procalcitonin in a Patient with Drug Hypersensitivity Syndrome
        Cytomegalovirus-associated Acute Gastric Mucosal Lesion in an Immunocompetent Host
        Mycobacterium Avium-Intracellulare Infection Presenting as a Testicular Mass in an Immunocompromised Patient: A Case Report

        Cases archive
          




        personal edition > immunology > webcasts/CME
        divider
        Webcasts/CME


          E-Mail this webcast/CME to a colleague




        news Biologic Therapies III The New Agents

        Presented by:The Cleveland Clinic Foundation Center for Continuing Education
        LecturerLeonard Calabrese, DO, Mark Genovese, MD, Edward Keystone, MD, FRCPC, Scott Plevy, MD, Josef Smolen, MD and E. William St. Clair, MD
        Approximate duration:2.5 hrs.
        Summary points:This audiovisual CME programme includes findings from the Biologics Therapies Summitt III, in which a panel of rheumatology experts describe the new approaches for targeting B cells for the treatment of autoimmune diseases, and review the potential efficacy and safety ramifications of intra-cellular enzyme inhibition.
        Accreditation:The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits. Expiration Date: September 4, 2011.
        Other:


        Additional Information

        Audio:Yes
        Video:Yes
        Text:No
        Pictures/Slides:Yes
        Discussion group:No
        Feedback possible:No
        Minimum connection needed:28.8
        Plugins needed:No
        Registration:No


        Go to webcast/CME

        E-Mail this webcast/CME to a colleague

        Remind me of this



        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.